PA

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$104M
Cap. Flow %
2.08%
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7 years
Top 10 Avg Time Held Equity + Options
2.9 years
Top 20 Avg Time Held Equity + Options
3.8 years
Avg Time Held Equity only
4.7 years
Top 10 Avg Time Held Equity only
2.9 years
Top 20 Avg Time Held Equity only
3.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.71%
2 Technology 17.21%
3 Healthcare 9.68%
4 Financials 7.2%
5 Communication Services 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RXRX icon
3651
Recursion Pharmaceuticals
RXRX
$2.01B
– –
-393
Closed -$2.2K –
RXST icon
3652
RxSight
RXST
$188M
– –
-56
Closed -$1.41K –
RYAM icon
3653
Rayonier Advanced Materials
RYAM
$477M
– –
-48
Closed -$276 –
SAH icon
3654
Sonic Automotive
SAH
$1.9B
– –
-7
Closed -$399 –
SANA icon
3655
Sana Biotechnology
SANA
$698M
– –
-67
Closed -$113 –
SBLK icon
3656
Star Bulk Carriers
SBLK
$3.34B
– –
-26
Closed -$405 –
SEMR icon
3657
DELISTED
Semrush
SEMR
– –
-54
Closed -$504 –
SMLR icon
3658
DELISTED
Semler Scientific
SMLR
– –
-8
Closed -$290 –
SPEU icon
3659
State Street SPDR Portfolio Europe ETF
SPEU
$691M
– –
-250
Closed -$11K –
SPRY icon
3660
ARS Pharmaceuticals
SPRY
$391M
– –
-38
Closed -$478 –
SSO icon
3661
ProShares Ultra S&P500
SSO
$8.89B
– –
-2
Closed -$63 –
STOK icon
3662
Stoke Therapeutics
STOK
$1.5B
– –
-24
Closed -$160 –
SYRE icon
3663
Spyre Therapeutics
SYRE
$7.35B
– –
-14
Closed -$226 –
TMCI icon
3664
Treace Medical Concepts
TMCI
$263M
– –
-148
Closed -$1.24K –
TOTL icon
3665
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.65B
– –
-7,060
Closed -$284K –
TXO icon
3666
TXO Partners LP
TXO
$790M
– –
-5
Closed -$96 –
UA icon
3667
Under Armour Class C
UA
$2B
– –
-42
Closed -$250 –
UDN icon
3668
Invesco DB US Dollar Index Bearish Fund
UDN
$102M
– –
-17,915
Closed -$314K –
ULH icon
3669
Universal Logistics Holdings
ULH
$444M
– –
-214
Closed -$5.62K –
UTMD icon
3670
Utah Medical Products
UTMD
$237M
– –
-57
Closed -$3.19K –
VERV icon
3671
DELISTED
Verve Therapeutics
VERV
– –
-23
Closed -$105 –
VVX icon
3672
V2X
VVX
$2.14B
– –
-4
Closed -$196 –
WEAV icon
3673
Weave Communications
WEAV
$595M
– –
-29
Closed -$322 –
WES icon
3674
Western Midstream Partners
WES
$18.5B
– –
-1
Closed -$30 –
WKC icon
3675
World Kinect Corp
WKC
$1.88B
– –
-92
Closed -$2.62K –

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.